Tumour-associated macrophages mediate the invasion and metastasis of bladder cancer cells through CXCL8

Hao Wu, Xiangxiang Zhang, Dali Han, +2

PeerJ

Screening and Identifying Immune-Related Cells and Genes in the Tumor Microenvironment of Bladder Urothelial Carcinoma: Based on TCGA Database and Bioinformatics

Jinlong Cao, Xin Yang, Jianpeng Li, +5

Frontiers in Oncology

Current status of diagnosis and treatment of bladder cancer in China – Analyses of Chinese Bladder Cancer Consortium database

Kaiwen Li, Tianxin Lin, Wei Xue, +84

Asian journal of urology

Identification of prognostic biomarkers associated with stromal cell infiltration in muscle‐invasive bladder cancer by bioinformatics analyses

Pan Li, Jinlong Cao, Jianpeng Li, +5

Cancer Medicine

Circulating Tumor DNA Analyses Predict Disease Recurrence in Non-Muscle-Invasive Bladder Cancer

Jinghua Zhang, Daofeng Dai, Junqiang Tian, +5

Frontiers in Oncology

Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapy

Dongdong Tang, Yan Yang, Yangyang Li, +11

Theranostics

Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector

Degui Wang, Zhiping Wang, Junqiang Tian, +5

Urologic Oncology Seminars and Original Investigations

UrologyGenitourinary CancerMedicineTissue-specific VectorCancer Biology +5

Comparison of open and intracorporeal modified ureterosigmoidostomy (Mainz II) after laparoscopic radical cystectomy with bladder cancer

Duo Zheng, Junyao Liu, Gongjin Wu, +9

World Journal of Surgical Oncology

Single-Use Digital Flexible Ureteroscopes as a Safe and Effective Choice for the Treatment of Lower Pole Renal Stones: Secondary Analysis of a Randomized-Controlled Trial

Enguang Yang, Suoshi Jing, Yuanjie Niu, +9

Journal of Endourology

Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis

Jianpeng Li, Jinlong Cao, Pan Li, +4

BMC Cancer